# Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets

> **NCT01387308** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fostamatinib
- **DRUG:** Fostamatinib
- **DRUG:** Fostamatinib
- **DRUG:** Fostamatinib
- **DRUG:** Fostamatinib

## Key facts

- **NCT ID:** NCT01387308
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387308, "Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01387308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*